These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24709834)

  • 1. Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.
    Marriott AC; Dove BK; Whittaker CJ; Bruce C; Ryan KA; Bean TJ; Rayner E; Pearson G; Taylor I; Dowall S; Plank J; Newman E; Barclay WS; Dimmock NJ; Easton AJ; Hallis B; Silman NJ; Carroll MW
    PLoS One; 2014; 9(4):e94090. PubMed ID: 24709834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.
    Govorkova EA; Marathe BM; Prevost A; Rehg JE; Webster RG
    Antiviral Res; 2011 Aug; 91(2):81-8. PubMed ID: 21635924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission.
    Lee LYY; Zhou J; Frise R; Goldhill DH; Koszalka P; Mifsud EJ; Baba K; Noda T; Ando Y; Sato K; Yuki AI; Shishido T; Uehara T; Wildum S; Zwanziger E; Collinson N; Kuhlbusch K; Clinch B; Hurt AC; Barclay WS
    PLoS Pathog; 2020 Apr; 16(4):e1008395. PubMed ID: 32294137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced airborne transmission of oseltamivir-resistant pandemic A/H1N1 virus in ferrets.
    Hamelin ME; Baz M; Bouhy X; Beaulieu E; Dubé K; Mallett C; Boivin G
    Antivir Ther; 2011; 16(5):775-9. PubMed ID: 21817200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel video tracking method to evaluate the effect of influenza infection and antiviral treatment on ferret activity.
    Oh DY; Barr IG; Hurt AC
    PLoS One; 2015; 10(3):e0118780. PubMed ID: 25738900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir.
    Dimmock NJ; Dove BK; Meng B; Scott PD; Taylor I; Cheung L; Hallis B; Marriott AC; Carroll MW; Easton AJ
    Antiviral Res; 2012 Dec; 96(3):376-85. PubMed ID: 23041142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.
    Oh DY; Lowther S; McCaw JM; Sullivan SG; Leang SK; Haining J; Arkinstall R; Kelso A; Mcvernon J; Barr IG; Middleton D; Hurt AC
    J Antimicrob Chemother; 2014 Sep; 69(9):2458-69. PubMed ID: 24840623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus.
    Govorkova EA; Ilyushina NA; Boltz DA; Douglas A; Yilmaz N; Webster RG
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1414-24. PubMed ID: 17296744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of Infection.
    Marriott AC; Dennis M; Kane JA; Gooch KE; Hatch G; Sharpe S; Prevosto C; Leeming G; Zekeng EG; Staples KJ; Hall G; Ryan KA; Bate S; Moyo N; Whittaker CJ; Hallis B; Silman NJ; Lalvani A; Wilkinson TM; Hiscox JA; Stewart JP; Carroll MW
    PLoS One; 2016; 11(6):e0157887. PubMed ID: 27311020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 feeding enhances humoral immune responses, which are suppressed by the antiviral neuraminidase inhibitor oseltamivir in influenza A virus-infected mice.
    Takahashi E; Sawabuchi T; Kimoto T; Sakai S; Kido H
    J Dairy Sci; 2019 Nov; 102(11):9559-9569. PubMed ID: 31495632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets.
    van der Vries E; Stittelaar KJ; van Amerongen G; Veldhuis Kroeze EJ; de Waal L; Fraaij PL; Meesters RJ; Luider TM; van der Nagel B; Koch B; Vulto AG; Schutten M; Osterhaus AD
    PLoS Pathog; 2013; 9(5):e1003343. PubMed ID: 23717200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses.
    Paules CI; Lakdawala S; McAuliffe JM; Paskel M; Vogel L; Kallewaard NL; Zhu Q; Subbarao K
    J Infect Dis; 2017 Aug; 216(3):356-365. PubMed ID: 28633457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses.
    Bird NL; Olson MR; Hurt AC; Oshansky CM; Oh DY; Reading PC; Chua BY; Sun Y; Tang L; Handel A; Jackson DC; Turner SJ; Thomas PG; Kedzierska K
    PLoS One; 2015; 10(6):e0129768. PubMed ID: 26086392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
    Hurt AC; Lowther S; Middleton D; Barr IG
    Antiviral Res; 2010 Sep; 87(3):361-6. PubMed ID: 20603155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.
    Pearce MB; Belser JA; Houser KV; Katz JM; Tumpey TM
    Vaccine; 2011 Apr; 29(16):2887-94. PubMed ID: 21338676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapy.
    Mifsud EJ; Tilmanis D; Oh DY; Ming-Kay Tai C; Rossignol JF; Hurt AC
    Antiviral Res; 2020 Apr; 176():104751. PubMed ID: 32088248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oseltamivir inhibits influenza virus replication and transmission following ocular-only aerosol inoculation of ferrets.
    Belser JA; Maines TR; Creager HM; Katz JM; Tumpey TM
    Virology; 2015 Oct; 484():305-312. PubMed ID: 26142497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.
    Ranadheera C; Hagan MW; Leung A; Collignon B; Cutts T; Theriault S; Embury-Hyatt C; Kobasa D
    J Virol; 2016 Nov; 90(21):9931-9941. PubMed ID: 27558428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance.
    Roosenhoff R; van der Vries E; van der Linden A; van Amerongen G; Stittelaar KJ; Smits SL; Schutten M; Fouchier RAM
    PLoS One; 2018; 13(7):e0200849. PubMed ID: 30024940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.